Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1526844

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1526844

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that offers comprehensive services for developing, formulating, and producing topical pharmaceuticals. These services encompass research and development, clinical trial material production, and commercial manufacturing. CDMOs assist pharmaceutical companies in bringing topical drug products to market efficiently and in compliance with regulations.

The main product types offered by topical drug CDMOs include semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations consist of creams, ointments, gels, and pastes designed for topical application. Various service types provided include contract development and contract manufacturing for therapeutic areas such as dermatology, pain management, wound care, and ophthalmology, among others. The end-users of these services include pharmaceutical companies, biopharmaceutical companies, and others.

The topical drug contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides topical drug contract development and manufacturing organization (CDMO) market statistics, including topical drug contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a topical drug contract development and manufacturing organization (CDMO) market share, detailed topical drug contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the topical drug contract development and manufacturing organization (CDMO) industry. This topical drug contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The topical drugs contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $45.47 billion in 2023 to $52.9 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth during the historic period can be attributed to several factors, including the prevalence of chronic diseases, advancements in drug delivery technologies, cost-efficient outsourcing, regulatory demands, and the expansion of the dermatology and cosmetics sectors.

The topical drugs contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $97.26 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to the expansion of personalized medicine and biologics, increased R&D investments, rising prevalence of skin disorders, and advancements in manufacturing technologies. Major trends during this period include the increasing demand for innovative formulations, advancements in drug delivery technologies, rising investments in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and growing consumer preference for over-the-counter (OTC) skincare products.

The increasing prevalence of skin diseases is expected to drive the growth of the topical drugs contract development and manufacturing organization (CDMO) market in the future. Skin diseases are medical conditions affecting the skin, causing symptoms such as inflammation, itching, and lesions. The rising prevalence of skin diseases can be attributed to factors such as environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. Topical drugs CDMOs help reduce skin disease prevalence by developing and manufacturing targeted therapies that improve the management and treatment of dermatological conditions. For example, in January 2024, Cancer Australia, an Australian-based cancer control agency, reported a significant increase in skin melanoma cases between 2019 and 2023, with numbers rising from 15,628 to 18,257. Additionally, in 2019, males had 9,134 cases compared to 6,494 females, while by 2023, the numbers had risen to 10,639 males and 7,618 females. Therefore, the increasing prevalence of skin diseases is driving the growth of the topical drugs CDMO market.

Major companies in the topical drugs CDMO market are focused on developing state-of-the-art manufacturing facilities to maintain their market position. A state-of-the-art manufacturing facility is a specialized production site equipped with the latest technology and advanced processes tailored for the development and manufacturing of topical pharmaceutical products. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, launched a CDMO GMP manufacturing facility. The new Carlsbad facility will offer ample space for manufacturing topical products and SOHM's operations, with 2,500 square feet dedicated to storing finished products. Initially, it will have a daily capacity of 500 gallons (1,892 liters) for manufacturing topicals. By the end of Q1 2024 or the start of Q2 2024, it is expected to expand its capacity to include soft-gel suppositories.

In April 2024, CoreRx Inc., a US-based pharmaceutical company, acquired Societal CDMO Inc. for $130 million. The acquisition is set to enhance CoreRx into a stronger CDMO, expanding its services from early-stage development to commercial manufacturing. It will streamline operations, increase market share, and provide long-term benefits such as improved economies of scale, better R&D, and a stronger competitive position. Societal CDMO Inc. is a US-based contract development and manufacturing organization that specializes in developing and manufacturing novel drug delivery formulations.

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd, Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The topical drugs contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as commercial manufacturing, research and development (R&D), regulatory support, and product lifecycle management. The market value includes the value of related goods sold by the service provider or included within the service offering. The topical drugs contract development and manufacturing organization (CDMO) market also includes sales of creams, ointments, gels, and lotions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on topical drugs contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for topical drugs contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The topical drugs contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Semi-Solid Formulations; Liquid Formulations Drugs; Solid Formulations; Transdermal Products
  • 2) By Service Type: Contract Development; Contract Manufacturing
  • 3) By Therapeutic Area: Dermatology; Pain Management; Wound Care; Ophthalmology; Other Therapeutic Areas
  • 4) By End-Use: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Uses
  • Companies Mentioned: Evonik Industries AG; Eurofins Scientific SE; SGS SA; The Lubrizol Corporation; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r18493

Table of Contents

1. Executive Summary

2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size and Growth

  • 5.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

  • 6.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Semi-Solid Formulations
  • Liquid Formulations Drugs
  • Solid Formulations
  • Transdermal Products
  • 6.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Development
  • Contract Manufacturing
  • 6.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dermatology
  • Pain Management
  • Wound Care
  • Ophthalmology
  • Other Therapeutic Areas
  • 6.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Other End-Uses

7. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

  • 7.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 8.1. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 9.1. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 9.2. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 10.1. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 11.1. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 11.2. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 12.1. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 13.1. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 14.1. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 14.2. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 15.1. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 15.2. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 16.1. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 17.1. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 18.1. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 19.1. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 20.1. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 21.1. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 21.2. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 22.1. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 23.1. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 23.2. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 24.1. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 24.2. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 25.1. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 25.2. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 26.1. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 26.2. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 27.1. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 28.1. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 28.2. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

  • 29.1. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 29.2. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

  • 30.1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
  • 30.2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
    • 30.2.1. Evonik Industries AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Eurofins Scientific SE
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. SGS SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. The Lubrizol Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Bora Pharmaceuticals Co. Ltd.
  • 31.3. Recipharm AB
  • 31.4. Pierre Fabre S.A.
  • 31.5. Piramal Pharma Solutions
  • 31.6. Cambrex Corporation
  • 31.7. LTS Lohmann Therapies-Systeme AG
  • 31.8. PCI Pharma Services
  • 31.9. Famar S.A.
  • 31.10. Contract Pharmaceuticals Limited
  • 31.11. UPM Pharmaceuticals Inc.
  • 31.12. CoreRx Inc.
  • 31.13. Halo Pharmaceutical Inc.
  • 31.14. Tapemark Company
  • 31.15. Groupe PARIMA Inc.

32. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking

33. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

35. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Future Outlook and Potential Analysis

  • 35.1 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!